The diagnosis, care and management of patients with neurodegeneration is more complex than ever. Understanding the etiology can lead to an accurate diagnosis and helps ensure patients and families receive appropriate care and access to clinical trials.
.svg)
The discovery of genetic forms of FTD has catalyzed research. Although there are no approved treatments yet, there are multiple trials in progress that, if successful, could change the disease trajectory for people with FTD who have GRN gene variants. Learn more about current clinical trials.
Search the Clinical Trial Directory15-20% of patients with FTD have an identifiable genetic cause,1,2 yet genetic testing is underutilized. Identifying which patients have a genetic variant has the potential to:
Learn more about our free genetic counseling and testing program, sponsored by the Bluefield Project to Cure FTD.
Keep up-to-date on the latest research and new advancements
Visit Our Resources
637 Carolina St.
San Francisco, CA 94107
navigator@bluefieldproject.org
